Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hsu

Showing results (351-360 of 521) with videos related to

Pageof 53
Sort By:
Cell Systems|December 13, 2023
Deep learning and CRISPR-Cas13d ortholog discovery for optimized RNA targetingJingyi Wei, Peter Lotfy, Kian Faizi, et al.
Journal of Neurointerventional Surgery|December 15, 2011
Society of NeuroInterventional Surgery Standards of Practice: general considerationsP M Meyers, K A Blackham, T A Abruzzo, et al.
Nature|June 26, 2024
Structural mechanism of bridge RNA-guided recombinationMasahiro Hiraizumi, Nicholas T Perry, Matthew G Durrant, et al.
The American Journal of Pathology|September 26, 2003
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histologyTorsten O Nielsen, Forrest D Hsu, John X O'Connell, et al.
Life Sciences|September 24, 2008
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune diseaseKevin Gillespie, Isamu Kodani, Douglas P Dickinson, et al.
Nature Biotechnology|April 23, 2014
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cellsXuebing Wu, David A Scott, Andrea J Kriz, et al.
Science (New York, N.Y.)|September 25, 2025
Megabase-scale human genome rearrangement with programmable bridge recombinasesNicholas T Perry, Liam J Bartie, Dhruva Katrekar, et al.
Human Gene Therapy|November 19, 2010
Current good manufacturing practice production of an oncolytic recombinant vesicular stomatitis viral vector for cancer treatmentL J Ausubel, M Meseck, I Derecho, et al.
Nature Biotechnology|July 23, 2013
DNA targeting specificity of RNA-guided Cas9 nucleasesPatrick D Hsu, David A Scott, Joshua A Weinstein, et al.
North Carolina Medical Journal|March 11, 2026
Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North CarolinaChristine D Hsu, Louise M Henderson, Bradford E Jackson, et al.
Pageof 53

Showing results (351-360 of 521) with videos related to

Sort By:
Pageof 53
Cell Systems|December 13, 2023
Deep learning and CRISPR-Cas13d ortholog discovery for optimized RNA targetingJingyi Wei, Peter Lotfy, Kian Faizi, et al.
Journal of Neurointerventional Surgery|December 15, 2011
Society of NeuroInterventional Surgery Standards of Practice: general considerationsP M Meyers, K A Blackham, T A Abruzzo, et al.
Nature|June 26, 2024
Structural mechanism of bridge RNA-guided recombinationMasahiro Hiraizumi, Nicholas T Perry, Matthew G Durrant, et al.
The American Journal of Pathology|September 26, 2003
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histologyTorsten O Nielsen, Forrest D Hsu, John X O'Connell, et al.
Life Sciences|September 24, 2008
Effects of oral consumption of the green tea polyphenol EGCG in a murine model for human Sjogren's syndrome, an autoimmune diseaseKevin Gillespie, Isamu Kodani, Douglas P Dickinson, et al.
Nature Biotechnology|April 23, 2014
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cellsXuebing Wu, David A Scott, Andrea J Kriz, et al.
Science (New York, N.Y.)|September 25, 2025
Megabase-scale human genome rearrangement with programmable bridge recombinasesNicholas T Perry, Liam J Bartie, Dhruva Katrekar, et al.
Human Gene Therapy|November 19, 2010
Current good manufacturing practice production of an oncolytic recombinant vesicular stomatitis viral vector for cancer treatmentL J Ausubel, M Meseck, I Derecho, et al.
Nature Biotechnology|July 23, 2013
DNA targeting specificity of RNA-guided Cas9 nucleasesPatrick D Hsu, David A Scott, Joshua A Weinstein, et al.
North Carolina Medical Journal|March 11, 2026
Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North CarolinaChristine D Hsu, Louise M Henderson, Bradford E Jackson, et al.
Pageof 53